Rua Bioscience begins importing MDMA for therapeutic use in New Zealand
1 report, 1 independent
Updated Oct 1
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Rua Bioscience began importing and distributing pharmaceutical-grade MDMA for therapeutic treatment of post-traumatic stress disorder. This process involved coordinating regulatory steps with Medsafe, which had previously granted two New Zealand psychiatrists approval to prescribe and administer the drug. The MDMA will be supplied by PharmAla Biotech on a consignment basis for the initial shipment.
From rnz.co.nz
Why it matters
The agreement establishes a regulated supply chain for MDMA in New Zealand for medical use. Rua Bioscience stated that their experience with medicinal cannabis applies to this new category, and they expect the field to grow as regulatory frameworks and evidence develop.
From rnz.co.nz